메뉴 건너뛰기




Volumn , Issue , 2008, Pages 105-132

Non-human Primate Models of Parkinson's Disease and Experimental Therapeutics

Author keywords

[No Author keywords available]

Indexed keywords


EID: 84882503151     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-374028-1.00009-9     Document Type: Chapter
Times cited : (1)

References (186)
  • 1
    • 0025078156 scopus 로고
    • Effects of L-DOPA on extracellular dopamine in striatum of normal and 6-hydroxydopamione-treated rats
    • Abercrombie E.D., Bonatz A.E., Zigmond M.J. Effects of L-DOPA on extracellular dopamine in striatum of normal and 6-hydroxydopamione-treated rats. Brain Res 1990, 525:36-44.
    • (1990) Brain Res , vol.525 , pp. 36-44
    • Abercrombie, E.D.1    Bonatz, A.E.2    Zigmond, M.J.3
  • 2
    • 0027236406 scopus 로고
    • Chronic administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine to monkeys: Behavioural, morphological and biochemical correlates
    • Albanese A., Granata R., Gregori B., Piccardi M.P., Colosimo C., Tonali P. Chronic administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine to monkeys: Behavioural, morphological and biochemical correlates. Neuroscience 1993, 55:823-832.
    • (1993) Neuroscience , vol.55 , pp. 823-832
    • Albanese, A.1    Granata, R.2    Gregori, B.3    Piccardi, M.P.4    Colosimo, C.5    Tonali, P.6
  • 4
    • 0024495170 scopus 로고
    • Preservation of dopamine release in the denervated striatum
    • Altar C.A., Marien M.R. Preservation of dopamine release in the denervated striatum. Neurosci Lett 1989, 96:329-334.
    • (1989) Neurosci Lett , vol.96 , pp. 329-334
    • Altar, C.A.1    Marien, M.R.2
  • 5
    • 0042032778 scopus 로고    scopus 로고
    • Sub-chronic administration of the dopamine D(1) antagonist SKF 83959 in bilaterally MPTP-treated rhesus monkeys: Stable therapeutic effects and wearing-off dyskinesia
    • Andringa G., Stoof J.C., Cools A.R. Sub-chronic administration of the dopamine D(1) antagonist SKF 83959 in bilaterally MPTP-treated rhesus monkeys: Stable therapeutic effects and wearing-off dyskinesia. Psychopharmacology (Berl) 1999, 146:328-334.
    • (1999) Psychopharmacology (Berl) , vol.146 , pp. 328-334
    • Andringa, G.1    Stoof, J.C.2    Cools, A.R.3
  • 6
    • 0026634005 scopus 로고
    • Behavioral analysis of unilateral monoamine depletion in the marmoset
    • Annett L.E., Rogers D.C., Hernandez T.D., Dunnett S.B. Behavioral analysis of unilateral monoamine depletion in the marmoset. Brain 1992, 115:825-856.
    • (1992) Brain , vol.115 , pp. 825-856
    • Annett, L.E.1    Rogers, D.C.2    Hernandez, T.D.3    Dunnett, S.B.4
  • 7
    • 0022589131 scopus 로고
    • Hemiparkinsonism in monkeys after unilateral internal carotid infusion of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
    • Bankiewicz K.S., Oldfield E.H., Chiueh C.C., Doppman J.L., Jacobowitz D.M., Kopin I.J. Hemiparkinsonism in monkeys after unilateral internal carotid infusion of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Life Sci 1986, 39:7-16.
    • (1986) Life Sci , vol.39 , pp. 7-16
    • Bankiewicz, K.S.1    Oldfield, E.H.2    Chiueh, C.C.3    Doppman, J.L.4    Jacobowitz, D.M.5    Kopin, I.J.6
  • 8
    • 33746834485 scopus 로고    scopus 로고
    • The proteasomal inhibition model of Parkinson's disease: "Boon or bust "?
    • Beal F., Lang A. The proteasomal inhibition model of Parkinson's disease: "Boon or bust"?. Ann Neurol 2006, 60:158-161.
    • (2006) Ann Neurol , vol.60 , pp. 158-161
    • Beal, F.1    Lang, A.2
  • 9
    • 0026607313 scopus 로고
    • Levodopa-induced dyskinesia: Facts and fancy. What does the MPTP monkey model tell us?
    • Bedard P.J., Mancilla B.G., Blanchette P., Gagnon C., Di Paolo T. Levodopa-induced dyskinesia: Facts and fancy. What does the MPTP monkey model tell us?. Can J Neurol Sci 1992, 19:134-137.
    • (1992) Can J Neurol Sci , vol.19 , pp. 134-137
    • Bedard, P.J.1    Mancilla, B.G.2    Blanchette, P.3    Gagnon, C.4    Di Paolo, T.5
  • 10
    • 0033977075 scopus 로고    scopus 로고
    • GluR1 glutamate receptor subunit is regulated differentially in the primate basal ganglia following nigrostriatal dopamine denervation
    • Betarbet R., Porter R.H., Greenamyre J.T. GluR1 glutamate receptor subunit is regulated differentially in the primate basal ganglia following nigrostriatal dopamine denervation. J Neurochem 2000, 74:1166-1174.
    • (2000) J Neurochem , vol.74 , pp. 1166-1174
    • Betarbet, R.1    Porter, R.H.2    Greenamyre, J.T.3
  • 11
    • 1842664191 scopus 로고    scopus 로고
    • Differential expression and ser897 phosphorylation of striatal N-methyl-d-aspartate receptor subunit NR1 in animal models of Parkinson's disease
    • Betarbet R., Poisik O., Sherer T.B., Greenamyre J.T. Differential expression and ser897 phosphorylation of striatal N-methyl-d-aspartate receptor subunit NR1 in animal models of Parkinson's disease. Exp Neurol 2004, 187:76-85.
    • (2004) Exp Neurol , vol.187 , pp. 76-85
    • Betarbet, R.1    Poisik, O.2    Sherer, T.B.3    Greenamyre, J.T.4
  • 12
    • 0031960890 scopus 로고    scopus 로고
    • Compensatory mechanisms in experimental and human parkinsonism: Towards a dynamic approach
    • Bezard E., Gross C. Compensatory mechanisms in experimental and human parkinsonism: Towards a dynamic approach. Prog Neurobiol 1998, 55:96-116.
    • (1998) Prog Neurobiol , vol.55 , pp. 96-116
    • Bezard, E.1    Gross, C.2
  • 13
    • 0030984413 scopus 로고    scopus 로고
    • A chronic MPTP model reproducing the slow evolution of Parkinson's disease: Evolution of motor symptoms in the monkey
    • Bezard E., Imbert C., Deloire X., Bioulac B., Gross C.E. A chronic MPTP model reproducing the slow evolution of Parkinson's disease: Evolution of motor symptoms in the monkey. Brain Res 1997, 766:107-112.
    • (1997) Brain Res , vol.766 , pp. 107-112
    • Bezard, E.1    Imbert, C.2    Deloire, X.3    Bioulac, B.4    Gross, C.E.5
  • 14
    • 0034571915 scopus 로고    scopus 로고
    • Spontaneous long-term compensatory dopaminergic sprouting in MPTP-treated mice
    • Bezard E., Dovero S., Imbert C., Boraud T., Gross C.E. Spontaneous long-term compensatory dopaminergic sprouting in MPTP-treated mice. Synapse 2000, 38:363-368.
    • (2000) Synapse , vol.38 , pp. 363-368
    • Bezard, E.1    Dovero, S.2    Imbert, C.3    Boraud, T.4    Gross, C.E.5
  • 15
    • 0035434121 scopus 로고    scopus 로고
    • Pathophysiology of levodopa-induced dyskinesia: potential for new therapies
    • Bezard E., Brotchie J.M., Gross C.E. Pathophysiology of levodopa-induced dyskinesia: potential for new therapies. Nat Rev Neurosci 2001, 2:577-588.
    • (2001) Nat Rev Neurosci , vol.2 , pp. 577-588
    • Bezard, E.1    Brotchie, J.M.2    Gross, C.E.3
  • 17
    • 0842277727 scopus 로고    scopus 로고
    • Adenosine receptors and L-DOPA-induced dyskinesia in Parkinson's disease: Potential targets for a new therapeutic approach
    • Blandini F. Adenosine receptors and L-DOPA-induced dyskinesia in Parkinson's disease: Potential targets for a new therapeutic approach. Exp Neurol 2003, 184:556-560.
    • (2003) Exp Neurol , vol.184 , pp. 556-560
    • Blandini, F.1
  • 19
    • 33846203285 scopus 로고    scopus 로고
    • Dopamine and adult neurogenesis
    • Borta A., Hoglinger G.U. Dopamine and adult neurogenesis. J Neurochem 2007, 100:587-595.
    • (2007) J Neurochem , vol.100 , pp. 587-595
    • Borta, A.1    Hoglinger, G.U.2
  • 21
    • 26444532429 scopus 로고    scopus 로고
    • Nondopaminergic mechanisms in levodopa-induced dyskinesia
    • Brotchie J.M. Nondopaminergic mechanisms in levodopa-induced dyskinesia. Mov Disord 2005, 20:919-931.
    • (2005) Mov Disord , vol.20 , pp. 919-931
    • Brotchie, J.M.1
  • 22
    • 0032736127 scopus 로고    scopus 로고
    • Quantitative assessment of dyskinesia in subhuman primates
    • Brotchie J.M., Fox S.H. Quantitative assessment of dyskinesia in subhuman primates. Mov Disord 1999, 14:40-47.
    • (1999) Mov Disord , vol.14 , pp. 40-47
    • Brotchie, J.M.1    Fox, S.H.2
  • 23
    • 0001496694 scopus 로고
    • A primate model of parkinsonism: Selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
    • Burns R.S., Chiueh C.C., Markey S.P., Ebert M.H., Jacobowitz D.M., Kopin I.J. A primate model of parkinsonism: Selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Proc Natl Acad Sci USA 1983, 80:4546-4550.
    • (1983) Proc Natl Acad Sci USA , vol.80 , pp. 4546-4550
    • Burns, R.S.1    Chiueh, C.C.2    Markey, S.P.3    Ebert, M.H.4    Jacobowitz, D.M.5    Kopin, I.J.6
  • 24
    • 0026526276 scopus 로고
    • Long-term synaptic depression in the striatum: Physiological and pharmacological characterization
    • Calabresi P., Maj R., Pisani A., Mercuri N.B., Bernardi G. Long-term synaptic depression in the striatum: Physiological and pharmacological characterization. J Neurosci 1992, 12:424-4233.
    • (1992) J Neurosci , vol.12 , pp. 424-4233
    • Calabresi, P.1    Maj, R.2    Pisani, A.3    Mercuri, N.B.4    Bernardi, G.5
  • 25
  • 26
    • 0029076807 scopus 로고
    • Levodopa or D2 agonists induce dyskinesia in MPTP monkeys: Correlation with changes in dopamine and GABA A receptors in the striatopallidal complex
    • Calon F., Goulet M., Blanchet P.J., Martel J.C., Piercey F., Bedard P.J., Di Paolo T. Levodopa or D2 agonists induce dyskinesia in MPTP monkeys: Correlation with changes in dopamine and GABA A receptors in the striatopallidal complex. Brain Res 1995, 680:43-52.
    • (1995) Brain Res , vol.680 , pp. 43-52
    • Calon, F.1    Goulet, M.2    Blanchet, P.J.3    Martel, J.C.4    Piercey, F.5    Bedard, P.J.6    Di Paolo, T.7
  • 27
    • 0036139613 scopus 로고    scopus 로고
    • Alteration of glutamate receptors in the striatum of dyskinetic 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated monkeys following dopamine agonist treatment
    • Calon F., Morissette M., Ghribi O., Goulet M., Grondin R., Blanchet P.J., Bedard P.J., Di Paolo T. Alteration of glutamate receptors in the striatum of dyskinetic 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated monkeys following dopamine agonist treatment. Prog Neuropsychopharmacol Biol Psychiatr 2002, 26:127-138.
    • (2002) Prog Neuropsychopharmacol Biol Psychiatr , vol.26 , pp. 127-138
    • Calon, F.1    Morissette, M.2    Ghribi, O.3    Goulet, M.4    Grondin, R.5    Blanchet, P.J.6    Bedard, P.J.7    Di Paolo, T.8
  • 28
    • 0025443256 scopus 로고
    • Changes in striatal dopamine neurotransmission assessed with microdialysis following recovery from a bilateral 6-OHDA lesion: Variation as a function of lesion size
    • Castaneda E., Whishaw I.Q., Robinson T.E. Changes in striatal dopamine neurotransmission assessed with microdialysis following recovery from a bilateral 6-OHDA lesion: Variation as a function of lesion size. J Neurosci 1990, 10:1847-1854.
    • (1990) J Neurosci , vol.10 , pp. 1847-1854
    • Castaneda, E.1    Whishaw, I.Q.2    Robinson, T.E.3
  • 31
    • 0035888924 scopus 로고    scopus 로고
    • Assessment of motor behavior using a video system and a clinical rating scale in parkinsonian monkeys lesioned by MPTP
    • Chassain C., Eschalier A., Durif F. Assessment of motor behavior using a video system and a clinical rating scale in parkinsonian monkeys lesioned by MPTP. J Neurosci Method 2001, 111:9-16.
    • (2001) J Neurosci Method , vol.111 , pp. 9-16
    • Chassain, C.1    Eschalier, A.2    Durif, F.3
  • 33
    • 0021339035 scopus 로고
    • Neurochemical and behavioral effects of systemic and intranigral administration of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in the rat
    • Chiueh C.C., Markey S.P., Burns R.S., Johannessen J.N., Pert A., Kopin I.J. Neurochemical and behavioral effects of systemic and intranigral administration of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in the rat. Eur J Pharmacol 1984, 100:189-194.
    • (1984) Eur J Pharmacol , vol.100 , pp. 189-194
    • Chiueh, C.C.1    Markey, S.P.2    Burns, R.S.3    Johannessen, J.N.4    Pert, A.5    Kopin, I.J.6
  • 34
    • 0021259475 scopus 로고
    • Selective neurotoxic effects of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in subhuman primates and man: A new animal model of Parkinson's disease
    • Chiueh C.C., Markey S.P., Burns R.S., Johannessen J.N., Jacobowitz D.M., Kopin I.J. Selective neurotoxic effects of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in subhuman primates and man: A new animal model of Parkinson's disease. Psychopharmac Bull 1984, 20:548-553.
    • (1984) Psychopharmac Bull , vol.20 , pp. 548-553
    • Chiueh, C.C.1    Markey, S.P.2    Burns, R.S.3    Johannessen, J.N.4    Jacobowitz, D.M.5    Kopin, I.J.6
  • 35
    • 33947211176 scopus 로고    scopus 로고
    • Aging-related changes in the nigrostriatal dopamine system and the response to MPTP in nonhuman primates: Diminished compensatory mechanisms as a prelude to parkinsonism
    • Collier T.J., Lipton J., Daley B.F., Palfi S., Chu Y., Sortwell C., Bakay R.A., Sladek J.R., Kordower J.H. Aging-related changes in the nigrostriatal dopamine system and the response to MPTP in nonhuman primates: Diminished compensatory mechanisms as a prelude to parkinsonism. Neurobiol Dis 2007, 26:56-65.
    • (2007) Neurobiol Dis , vol.26 , pp. 56-65
    • Collier, T.J.1    Lipton, J.2    Daley, B.F.3    Palfi, S.4    Chu, Y.5    Sortwell, C.6    Bakay, R.A.7    Sladek, J.R.8    Kordower, J.H.9
  • 36
    • 0021992979 scopus 로고
    • Beta-carboline analogues of N-methyl-4-phenyl-1,2,5,6-tetrahydropyridine (MPTP): Endogenous factors underlying idiopathic parkinsonism?
    • Collins M.A., Neafsey E.J. Beta-carboline analogues of N-methyl-4-phenyl-1,2,5,6-tetrahydropyridine (MPTP): Endogenous factors underlying idiopathic parkinsonism?. Neurosci Lett 1985, 55:179-184.
    • (1985) Neurosci Lett , vol.55 , pp. 179-184
    • Collins, M.A.1    Neafsey, E.J.2
  • 37
    • 34247189165 scopus 로고    scopus 로고
    • The selective kappa-opioid receptor agonist U50,488 reduces l-dopa-induced dyskinesias but worsens parkinsonism in MPTP-treated primates
    • Cox H., Togasaki D.M., Chen L., Langston J.W., Di Monte D.A., Quik M. The selective kappa-opioid receptor agonist U50,488 reduces l-dopa-induced dyskinesias but worsens parkinsonism in MPTP-treated primates. Exp Neurol 2007.
    • (2007) Exp Neurol
    • Cox, H.1    Togasaki, D.M.2    Chen, L.3    Langston, J.W.4    Di Monte, D.A.5    Quik, M.6
  • 38
    • 0037704408 scopus 로고    scopus 로고
    • Variable dopamine release probability and short-term plasticity between functional domains of the primate striatum
    • Cragg S.J. Variable dopamine release probability and short-term plasticity between functional domains of the primate striatum. Trends Neurosci 2003, 23:4378-4385.
    • (2003) Trends Neurosci , vol.23 , pp. 4378-4385
    • Cragg, S.J.1
  • 39
    • 0021849088 scopus 로고
    • Regional brain uptake of 2-deoxyglucose in N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced parkinsonism in the macaque monkey
    • Crossman A.R., Mitchell I.J., Sambrook M.A. Regional brain uptake of 2-deoxyglucose in N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced parkinsonism in the macaque monkey. Neuropharmacology 1985, 24:587-591.
    • (1985) Neuropharmacology , vol.24 , pp. 587-591
    • Crossman, A.R.1    Mitchell, I.J.2    Sambrook, M.A.3
  • 40
    • 0030272681 scopus 로고    scopus 로고
    • Evidence for the Hebbian hypothesis in experience-dependent physiological plasticity of neocortex: A critical review
    • Cruikshank S.J., Weinberger N.M. Evidence for the Hebbian hypothesis in experience-dependent physiological plasticity of neocortex: A critical review. Brain Res Rev 1996, 22:191-228.
    • (1996) Brain Res Rev , vol.22 , pp. 191-228
    • Cruikshank, S.J.1    Weinberger, N.M.2
  • 41
    • 0027153134 scopus 로고
    • Plasticity of the nigrostriatal system in MPTP-treated mice. A biochemical and morphological correlation
    • Cruz-Sanchez F.F., Cardozo A., Ambrosio S., Tolosa E., Mahy N. Plasticity of the nigrostriatal system in MPTP-treated mice. A biochemical and morphological correlation. Mol Chem Neuropathol 1993, 19:163-176.
    • (1993) Mol Chem Neuropathol , vol.19 , pp. 163-176
    • Cruz-Sanchez, F.F.1    Cardozo, A.2    Ambrosio, S.3    Tolosa, E.4    Mahy, N.5
  • 42
    • 4544299513 scopus 로고    scopus 로고
    • Methamphetamine discrimination and in vivo microdialysis in squirrel monkeys
    • Czoty P.W., Makriyannis A., Bergman J. Methamphetamine discrimination and in vivo microdialysis in squirrel monkeys. Psychopharmacology (Berl) 2004, 175:170-178.
    • (2004) Psychopharmacology (Berl) , vol.175 , pp. 170-178
    • Czoty, P.W.1    Makriyannis, A.2    Bergman, J.3
  • 43
    • 0141741347 scopus 로고    scopus 로고
    • Parkinson's disease: Mechanisms and models
    • Dauer W., Przedborski S. Parkinson's disease: Mechanisms and models. Neuron 2003, 39:889-909.
    • (2003) Neuron , vol.39 , pp. 889-909
    • Dauer, W.1    Przedborski, S.2
  • 44
    • 0034882387 scopus 로고    scopus 로고
    • Methamphetamine neurotoxicity: Necrotic and apoptotic mechanisms and relevance to human abuse and treatment
    • Davidson C., Gow A.J., Lee M.K., Ellinwood E.H. Methamphetamine neurotoxicity: Necrotic and apoptotic mechanisms and relevance to human abuse and treatment. Brain Res Brain Res Rev 2001, 36:1-22.
    • (2001) Brain Res Brain Res Rev , vol.36 , pp. 1-22
    • Davidson, C.1    Gow, A.J.2    Lee, M.K.3    Ellinwood, E.H.4
  • 46
    • 4544368233 scopus 로고    scopus 로고
    • Attention and executive function deficits in chronic low-dose MPTP-treated non-human primates
    • Decamp E., Schneider J.S. Attention and executive function deficits in chronic low-dose MPTP-treated non-human primates. Eur J Neurosci 2004, 20:1371-1378.
    • (2004) Eur J Neurosci , vol.20 , pp. 1371-1378
    • Decamp, E.1    Schneider, J.S.2
  • 47
    • 2942534726 scopus 로고    scopus 로고
    • Attentional cueing reverses deficits in spatial working memory task performance in chronic low dose MPTP-treated monkeys
    • Decamp E., Tinker J.P., Schneider J.S. Attentional cueing reverses deficits in spatial working memory task performance in chronic low dose MPTP-treated monkeys. Behav Brain Res 2004, 152:259-262.
    • (2004) Behav Brain Res , vol.152 , pp. 259-262
    • Decamp, E.1    Tinker, J.P.2    Schneider, J.S.3
  • 48
    • 0034114557 scopus 로고    scopus 로고
    • Relationship among nigrostriatal denervation, parkinsonism, and dyskinesias in the MPTP primate model
    • Di Monte D.A., McCormack A., Petzinger G., Janson A.M., Quik M., Langston W.J. Relationship among nigrostriatal denervation, parkinsonism, and dyskinesias in the MPTP primate model. Mov Disord 2000, 15:459-466.
    • (2000) Mov Disord , vol.15 , pp. 459-466
    • Di Monte, D.A.1    McCormack, A.2    Petzinger, G.3    Janson, A.M.4    Quik, M.5    Langston, W.J.6
  • 50
    • 0022511809 scopus 로고
    • Variability and functional recovery in the N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of parkinsonism in monkeys
    • Eidelberg E., Brooks B.A., Morgan W.W., Walden J.G., Kokemoor R.H. Variability and functional recovery in the N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of parkinsonism in monkeys. Neurosci 1986, 18:817-822.
    • (1986) Neurosci , vol.18 , pp. 817-822
    • Eidelberg, E.1    Brooks, B.A.2    Morgan, W.W.3    Walden, J.G.4    Kokemoor, R.H.5
  • 51
    • 0024850382 scopus 로고
    • Symptomatic and asymptomatic 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated primates: biochemical changes in striatal regions
    • Elsworth J.D., Deutch A.Y., et al. Symptomatic and asymptomatic 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated primates: biochemical changes in striatal regions. Neuroscience 1989, 33(2):323-331.
    • (1989) Neuroscience , vol.33 , Issue.2 , pp. 323-331
    • Elsworth, J.D.1    Deutch, A.Y.2
  • 52
    • 0025194696 scopus 로고
    • MPTP-induced parkinsonism: Relative changes in dopamine concentration in subregions of substantia nigra, ventral tegmental area and retrorubal field of symptomatic and asymptomatic vervet monkeys
    • Elsworth J.D., Deutch A.Y., Redmond D.E., Sladek J.R., Roth R.H. MPTP-induced parkinsonism: Relative changes in dopamine concentration in subregions of substantia nigra, ventral tegmental area and retrorubal field of symptomatic and asymptomatic vervet monkeys. Brain Res 1990, 513:320-324.
    • (1990) Brain Res , vol.513 , pp. 320-324
    • Elsworth, J.D.1    Deutch, A.Y.2    Redmond, D.E.3    Sladek, J.R.4    Roth, R.H.5
  • 53
    • 0032738101 scopus 로고    scopus 로고
    • Striatal dopaminergic correlates of stable parkinsonism and degree of recovery in old-world primates one year after MPTP treatment
    • Elsworth J.D., Taylor J.R., Sladek J.R., Collier T.J., Redmond D.E., Roth R.H. Striatal dopaminergic correlates of stable parkinsonism and degree of recovery in old-world primates one year after MPTP treatment. Neurosci 2000, 95:399-408.
    • (2000) Neurosci , vol.95 , pp. 399-408
    • Elsworth, J.D.1    Taylor, J.R.2    Sladek, J.R.3    Collier, T.J.4    Redmond, D.E.5    Roth, R.H.6
  • 55
    • 28144449393 scopus 로고    scopus 로고
    • Marmoset monkey models of Parkinson's disease: Which model, when and why?
    • Eslamboli A. Marmoset monkey models of Parkinson's disease: Which model, when and why?. Brain Res Bull 2005, 68:140-149.
    • (2005) Brain Res Bull , vol.68 , pp. 140-149
    • Eslamboli, A.1
  • 57
    • 0029981526 scopus 로고    scopus 로고
    • Neuropathology of Parkinson's disease
    • Forno L.S. Neuropathology of Parkinson's disease. J Neuropath Exp Neurol 1996, 55:259-272.
    • (1996) J Neuropath Exp Neurol , vol.55 , pp. 259-272
    • Forno, L.S.1
  • 58
    • 0002538260 scopus 로고
    • Neuropathology of MPTP-treated monkeys. Comparison with the neuropathology of human idiopathic Parkinson's Disease
    • Academic Press, S.P. Markey, N.J. Castagnoli, A.J. Trevor, I.J. Kopin (Eds.)
    • Forno L.S., DeLanney L.E., Irwin I., Langston J.W. Neuropathology of MPTP-treated monkeys. Comparison with the neuropathology of human idiopathic Parkinson's Disease. MPTP: A Neurotoxin Producing a Parkinsonian Syndrom 1986, 119-139. Academic Press. S.P. Markey, N.J. Castagnoli, A.J. Trevor, I.J. Kopin (Eds.).
    • (1986) MPTP: A Neurotoxin Producing a Parkinsonian Syndrom , pp. 119-139
    • Forno, L.S.1    DeLanney, L.E.2    Irwin, I.3    Langston, J.W.4
  • 59
    • 0022466381 scopus 로고
    • Locus ceruleus lesions and eosinophilic inclusions in MPTP-treated monkeys
    • Forno L.S., Langston J.W., DeLanney L.E., Irwin I., Ricaurte G.A. Locus ceruleus lesions and eosinophilic inclusions in MPTP-treated monkeys. Ann Neurol 1986, 20:449-455.
    • (1986) Ann Neurol , vol.20 , pp. 449-455
    • Forno, L.S.1    Langston, J.W.2    DeLanney, L.E.3    Irwin, I.4    Ricaurte, G.A.5
  • 60
    • 0027343340 scopus 로고
    • Similarities and differences between MPTP-induced parkinsonsim and Parkinson's disease. Neuropathologic considerations
    • Forno L.S., DeLanney L.E., Irwin I., Langston J.W. Similarities and differences between MPTP-induced parkinsonsim and Parkinson's disease. Neuropathologic considerations. Adv Neurol 1993, 60:600-608.
    • (1993) Adv Neurol , vol.60 , pp. 600-608
    • Forno, L.S.1    DeLanney, L.E.2    Irwin, I.3    Langston, J.W.4
  • 61
    • 0036868444 scopus 로고    scopus 로고
    • Stimulation of cannabinoid receptors reduces levodopa-induced dyskinesia in the MPTP-lesioned nonhuman primate model of Parkinson's disease
    • Fox S.H., Henry B., Hill M., Crossman A., Brotchie J. Stimulation of cannabinoid receptors reduces levodopa-induced dyskinesia in the MPTP-lesioned nonhuman primate model of Parkinson's disease. Mov Disord 2002, 17:1180-1187.
    • (2002) Mov Disord , vol.17 , pp. 1180-1187
    • Fox, S.H.1    Henry, B.2    Hill, M.3    Crossman, A.4    Brotchie, J.5
  • 62
    • 0002312445 scopus 로고
    • Fetal substantia nigra transplants lead to dopamine cell replacement and behavioral improvement in Bonnet monkeys with MPTP induced parkinsonism
    • MacMillan Press, London, P.M. Beart, G.N. Woodruff (Eds.)
    • Freed C.R., Richards J.B., Sabol K.E., Reite M.L. Fetal substantia nigra transplants lead to dopamine cell replacement and behavioral improvement in Bonnet monkeys with MPTP induced parkinsonism. Jackson DMPharmacology and Functional Regulation of Dopaminergic Neurons 1988, 353-360. MacMillan Press, London. P.M. Beart, G.N. Woodruff (Eds.).
    • (1988) Jackson DMPharmacology and Functional Regulation of Dopaminergic Neurons , pp. 353-360
    • Freed, C.R.1    Richards, J.B.2    Sabol, K.E.3    Reite, M.L.4
  • 63
    • 0025334964 scopus 로고
    • Neurochemical and toxic effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and 1-methyl-4-phenylpyridine to rat serotonin neurons in dissociated cell cultures
    • Friedman L.K., Mytilineou C. Neurochemical and toxic effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and 1-methyl-4-phenylpyridine to rat serotonin neurons in dissociated cell cultures. J Pharmacol Exp Ther 1990, 253:892-898.
    • (1990) J Pharmacol Exp Ther , vol.253 , pp. 892-898
    • Friedman, L.K.1    Mytilineou, C.2
  • 64
    • 0028918337 scopus 로고
    • Alterations in dopamine uptake sites and D1 and D2 receptors in cats symptomatic for and recovered from experimental parkinsonism
    • Frohna P.A., Rothblat D.S., Joyce J.N., Schneider J.S. Alterations in dopamine uptake sites and D1 and D2 receptors in cats symptomatic for and recovered from experimental parkinsonism. Synapse 1995, 19:46-55.
    • (1995) Synapse , vol.19 , pp. 46-55
    • Frohna, P.A.1    Rothblat, D.S.2    Joyce, J.N.3    Schneider, J.S.4
  • 65
    • 0033668942 scopus 로고    scopus 로고
    • Effects of methamphetamine-induced neurotoxicity on the development of neural circuitry: A hypothesis
    • Frost D.O., Cadet J.L. Effects of methamphetamine-induced neurotoxicity on the development of neural circuitry: A hypothesis. Brain Res Brain Res Rev 2000, 34:103-118.
    • (2000) Brain Res Brain Res Rev , vol.34 , pp. 103-118
    • Frost, D.O.1    Cadet, J.L.2
  • 66
    • 0030877835 scopus 로고    scopus 로고
    • Dopamine transporter is required for in vivo MPTP neurotoxicity: evidence from mice lacking the transporter
    • Gainetdinov R.R., Fumagalli F., et al. Dopamine transporter is required for in vivo MPTP neurotoxicity: evidence from mice lacking the transporter. J Neurochem. 1997, 69(3):1322-1325.
    • (1997) J Neurochem. , vol.69 , Issue.3 , pp. 1322-1325
    • Gainetdinov, R.R.1    Fumagalli, F.2
  • 67
    • 0029845140 scopus 로고    scopus 로고
    • Animal models of Parkinson's disease: An empiracal comparison with the phenomenology of the disease in man
    • Gerlach M., Reiderer P. Animal models of Parkinson's disease: An empiracal comparison with the phenomenology of the disease in man. J Neural Transm 1996, 103:987-1041.
    • (1996) J Neural Transm , vol.103 , pp. 987-1041
    • Gerlach, M.1    Reiderer, P.2
  • 68
    • 0023830780 scopus 로고
    • 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonian syndrome in Macca fasicularis: Which midbrain dopaminergic neurons are lost?
    • German D., Dubach M., Askari S., Speciale S., Bowden D. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonian syndrome in Macca fasicularis: Which midbrain dopaminergic neurons are lost?. Neurosci 1988, 24:161-174.
    • (1988) Neurosci , vol.24 , pp. 161-174
    • German, D.1    Dubach, M.2    Askari, S.3    Speciale, S.4    Bowden, D.5
  • 69
    • 0036615887 scopus 로고    scopus 로고
    • Enhanced synchrony among primary motor cortex neurons in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine primate model of Parkinson's disease
    • Goldberg J.A., Boraud T., Maraton S., Haber S.N., Vaadia E., Bergman H. Enhanced synchrony among primary motor cortex neurons in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine primate model of Parkinson's disease. J Neurosci 2002, 22:4639-4653.
    • (2002) J Neurosci , vol.22 , pp. 4639-4653
    • Goldberg, J.A.1    Boraud, T.2    Maraton, S.3    Haber, S.N.4    Vaadia, E.5    Bergman, H.6
  • 70
    • 0035693854 scopus 로고    scopus 로고
    • Is methamphetamine abuse a risk factor in parkinsonism?
    • Guilarte T.R. Is methamphetamine abuse a risk factor in parkinsonism?. Neurotoxicol 2001, 22:725-731.
    • (2001) Neurotoxicol , vol.22 , pp. 725-731
    • Guilarte, T.R.1
  • 71
    • 14744290753 scopus 로고    scopus 로고
    • Alterations of striatal NMDA receptor subunits associated with the development of dyskinesia in the MPTP-lesioned primate model of Parkinson's disease
    • Hallett P.J., Dunah A.W., Ravenscroft P., Zhou S., Bezard E., Crossman A.R., Brotchie J.M., Standaert D.G. Alterations of striatal NMDA receptor subunits associated with the development of dyskinesia in the MPTP-lesioned primate model of Parkinson's disease. Neuropharmacology 2005, 48:503-516.
    • (2005) Neuropharmacology , vol.48 , pp. 503-516
    • Hallett, P.J.1    Dunah, A.W.2    Ravenscroft, P.3    Zhou, S.4    Bezard, E.5    Crossman, A.R.6    Brotchie, J.M.7    Standaert, D.G.8
  • 72
    • 0027535984 scopus 로고
    • Stable parkinsonian syndrome and uneven loss of striatal dopamine fibres following chronic MPTP administration in baboons
    • Hantraye P., Varastet M., Peschanski M., Riche D., Cesaro P., Willer J.C., Maziere M. Stable parkinsonian syndrome and uneven loss of striatal dopamine fibres following chronic MPTP administration in baboons. Neurosci 1993, 53:169-178.
    • (1993) Neurosci , vol.53 , pp. 169-178
    • Hantraye, P.1    Varastet, M.2    Peschanski, M.3    Riche, D.4    Cesaro, P.5    Willer, J.C.6    Maziere, M.7
  • 73
    • 0033911724 scopus 로고    scopus 로고
    • Regional heterogeneity of dopaminergic deficits in vervet monkey striatum and substantia nigra after methamphetamine exposure
    • Harvey D.C., Lacan G., Melega W.P. Regional heterogeneity of dopaminergic deficits in vervet monkey striatum and substantia nigra after methamphetamine exposure. Exp Brain Res 2000, 133:349-358.
    • (2000) Exp Brain Res , vol.133 , pp. 349-358
    • Harvey, D.C.1    Lacan, G.2    Melega, W.P.3
  • 74
    • 0034698409 scopus 로고    scopus 로고
    • Recovery from methamphetamine induced long-term nigrostriatal dopaminergic deficits without substantia nigra cell loss
    • Harvey D.C., Lacan G., Tanious S.P., Melega W.P. Recovery from methamphetamine induced long-term nigrostriatal dopaminergic deficits without substantia nigra cell loss. Brain Res 2000, 871:259-270.
    • (2000) Brain Res , vol.871 , pp. 259-270
    • Harvey, D.C.1    Lacan, G.2    Tanious, S.P.3    Melega, W.P.4
  • 75
    • 0032145369 scopus 로고    scopus 로고
    • Induction of interleukin-1 associated with compensatory dopaminergic sprouting in the denervated striatum of young mice: Model of aging and neurodegenerative disease
    • Ho A., Blum M. Induction of interleukin-1 associated with compensatory dopaminergic sprouting in the denervated striatum of young mice: Model of aging and neurodegenerative disease. J Neurosci 1998, 18:5614-5629.
    • (1998) J Neurosci , vol.18 , pp. 5614-5629
    • Ho, A.1    Blum, M.2
  • 76
    • 6344272628 scopus 로고    scopus 로고
    • Effect of the D3 Dopamine Receptor Partial Agonist BP897 on L-dopa-Induced Dyskinesias and Parkinsonism in Squirrel Monkeys
    • Hsu A., Togasaki D.M., Bezard E., Sokoloff P., Langston J.W., Di Monte D.A., Quik M. Effect of the D3 Dopamine Receptor Partial Agonist BP897 on L-dopa-Induced Dyskinesias and Parkinsonism in Squirrel Monkeys. J Pharmacol Exp Ther 2004, 311:770-777.
    • (2004) J Pharmacol Exp Ther , vol.311 , pp. 770-777
    • Hsu, A.1    Togasaki, D.M.2    Bezard, E.3    Sokoloff, P.4    Langston, J.W.5    Di Monte, D.A.6    Quik, M.7
  • 77
    • 0035809803 scopus 로고    scopus 로고
    • Dopamine D1 receptor expression in human basal ganglia and changes in Parkinson's disease
    • Hurley M.J., Mash D.C., Jenner P. Dopamine D1 receptor expression in human basal ganglia and changes in Parkinson's disease. Brain Res Mol Brain Res 2001, 87:271-279.
    • (2001) Brain Res Mol Brain Res , vol.87 , pp. 271-279
    • Hurley, M.J.1    Mash, D.C.2    Jenner, P.3
  • 78
    • 21844449693 scopus 로고    scopus 로고
    • Immunoautoradiographic analysis of NMDA receptor subunits and associated postsynaptic density proteins in the brain of dyskinetic MPTP-treated common marmosets
    • Hurley M.J., Jackson M.J., Smith L.A., Rose S., Jenner P. Immunoautoradiographic analysis of NMDA receptor subunits and associated postsynaptic density proteins in the brain of dyskinetic MPTP-treated common marmosets. Eur J Neurosci 2005, 21:3240-3250.
    • (2005) Eur J Neurosci , vol.21 , pp. 3240-3250
    • Hurley, M.J.1    Jackson, M.J.2    Smith, L.A.3    Rose, S.4    Jenner, P.5
  • 79
    • 0033993550 scopus 로고    scopus 로고
    • Comparison of eight clinical rating scales used for the assessment of MPTP-induced parkinsonism in the Macaque monkey
    • Imbert C., Bezard E., Guitraud S., Boraud T., Gross C.E. Comparison of eight clinical rating scales used for the assessment of MPTP-induced parkinsonism in the Macaque monkey. J Neurosci Method 2000, 96:71-76.
    • (2000) J Neurosci Method , vol.96 , pp. 71-76
    • Imbert, C.1    Bezard, E.2    Guitraud, S.3    Boraud, T.4    Gross, C.E.5
  • 80
    • 0021893794 scopus 로고
    • Selective accumulation of MPP+ in the substantianigra: a key to neurotoxicity?
    • Irwin I., Langston J.W. Selective accumulation of MPP+ in the substantianigra: a key to neurotoxicity?. Life Sci. 1985, 36(3):207-212.
    • (1985) Life Sci. , vol.36 , Issue.3 , pp. 207-212
    • Irwin, I.1    Langston, J.W.2
  • 81
    • 0025088849 scopus 로고
    • The evolution of nigrostriatal neurochemical changes in the MPTP-treated squirrel monkey
    • Irwin I., DeLanney L.E., Forno L.S., Finnegan K.T., Di Monte D., Langston J.W. The evolution of nigrostriatal neurochemical changes in the MPTP-treated squirrel monkey. Brain Res 1990, 531:242-252.
    • (1990) Brain Res , vol.531 , pp. 242-252
    • Irwin, I.1    DeLanney, L.E.2    Forno, L.S.3    Finnegan, K.T.4    Di Monte, D.5    Langston, J.W.6
  • 82
    • 38649126183 scopus 로고    scopus 로고
    • Pathophysiology of the basal ganglia and movement disorders: From animal models to human clinical applications
    • Israel Z., Bergman H. Pathophysiology of the basal ganglia and movement disorders: From animal models to human clinical applications. NeurosciBiobehav Rev. 2008, 32(3):367-377.
    • (2008) NeurosciBiobehav Rev. , vol.32 , Issue.3 , pp. 367-377
    • Israel, Z.1    Bergman, H.2
  • 83
    • 21744440118 scopus 로고    scopus 로고
    • MPTP and SNpc DA neuronal vulnerability: Role of dopamine, superoxide and nitric oxide in neurotoxicity
    • Jackson-Lewis V., Smeyne R.J. MPTP and SNpc DA neuronal vulnerability: Role of dopamine, superoxide and nitric oxide in neurotoxicity. Minireview. Neurotox Res, 2005, 7:193-202.
    • (2005) Minireview. Neurotox Res , vol.7 , pp. 193-202
    • Jackson-Lewis, V.1    Smeyne, R.J.2
  • 84
    • 34347259269 scopus 로고    scopus 로고
    • Protocol for the MPTP mouse model of Parkinson's disease
    • Jackson-Lewis V., Przedborski S. Protocol for the MPTP mouse model of Parkinson's disease. Nat Protoc 2007, 2:141-151.
    • (2007) Nat Protoc , vol.2 , pp. 141-151
    • Jackson-Lewis, V.1    Przedborski, S.2
  • 85
    • 0028784523 scopus 로고
    • Time course and morphology of dopaminergic neuronal death caused by the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
    • Jackson-Lewis V., Jakowec M., Burke R.E., Przedborski S. Time course and morphology of dopaminergic neuronal death caused by the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Neurodegen 1995, 4:257-269.
    • (1995) Neurodegen , vol.4 , pp. 257-269
    • Jackson-Lewis, V.1    Jakowec, M.2    Burke, R.E.3    Przedborski, S.4
  • 87
    • 2342503324 scopus 로고    scopus 로고
    • Tyrosine hydroxylase and dopamine transporter expression following 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neuro-degeneration in the mouse nigrostriatal pathway
    • Jakowec M.W., Nixon K., Hogg L., McNeill T., Petzinger G.M. Tyrosine hydroxylase and dopamine transporter expression following 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neuro-degeneration in the mouse nigrostriatal pathway. J Neurosci Res 2004, 76:539-550.
    • (2004) J Neurosci Res , vol.76 , pp. 539-550
    • Jakowec, M.W.1    Nixon, K.2    Hogg, L.3    McNeill, T.4    Petzinger, G.M.5
  • 88
    • 0035233512 scopus 로고    scopus 로고
    • The pathology of Parkinson's disease
    • Jellinger K.A. The pathology of Parkinson's disease. Adv Neurol 2001, 86:55-72.
    • (2001) Adv Neurol , vol.86 , pp. 55-72
    • Jellinger, K.A.1
  • 89
    • 0037269421 scopus 로고    scopus 로고
    • The contribution of the MPTP-treated primate model to the development of new treatment strategies for Parkinson's disease
    • Jenner P. The contribution of the MPTP-treated primate model to the development of new treatment strategies for Parkinson's disease. Parkinsonism Relat. Disord. 2003, 9(3):131-137.
    • (2003) Parkinsonism Relat. Disord. , vol.9 , Issue.3 , pp. 131-137
    • Jenner, P.1
  • 90
    • 0006460747 scopus 로고
    • MPTP-induced parkinsonism as an experimental model of Parkinson's disease
    • Urban and Schwarzenberg, Inc, Baltimore, J. Jankovic, E. Tolosa (Eds.)
    • Jenner P., Marsden C.D. MPTP-induced parkinsonism as an experimental model of Parkinson's disease. Parkinson's Disease and Movement Disorders 1988, 37-48. Urban and Schwarzenberg, Inc, Baltimore. J. Jankovic, E. Tolosa (Eds.).
    • (1988) Parkinson's Disease and Movement Disorders , pp. 37-48
    • Jenner, P.1    Marsden, C.D.2
  • 91
    • 0023173617 scopus 로고
    • MPTP-induced parkinsonism in the common marmoset: Behavioral and biochemical effects
    • Jenner P., Rose S., Nomoto M., Marsden C.D. MPTP-induced parkinsonism in the common marmoset: Behavioral and biochemical effects. Adv Neurol 1986, 45:183-186.
    • (1986) Adv Neurol , vol.45 , pp. 183-186
    • Jenner, P.1    Rose, S.2    Nomoto, M.3    Marsden, C.D.4
  • 92
    • 0024456094 scopus 로고
    • Regulation of the mesocortocolimbic dopamine system by glutamic acid receptor subtypes
    • Kalivas P.W., Duffy P., Barrow J. Regulation of the mesocortocolimbic dopamine system by glutamic acid receptor subtypes. J Pharmacol Exp Therap 1989, 251:378-387.
    • (1989) J Pharmacol Exp Therap , vol.251 , pp. 378-387
    • Kalivas, P.W.1    Duffy, P.2    Barrow, J.3
  • 93
    • 0031594271 scopus 로고    scopus 로고
    • Adenosine A2A antagonist: A novel antiparkinsonian agent that does not provoke dyskinesia in parkinsonian monkeys
    • Kanda T., Jackson M.J., Smith L.A., Pearce R.K., Nakamura J., Kase H., Kuwana Y., Jenner P. Adenosine A2A antagonist: A novel antiparkinsonian agent that does not provoke dyskinesia in parkinsonian monkeys. Ann Neurol 1998, 43:507-513.
    • (1998) Ann Neurol , vol.43 , pp. 507-513
    • Kanda, T.1    Jackson, M.J.2    Smith, L.A.3    Pearce, R.K.4    Nakamura, J.5    Kase, H.6    Kuwana, Y.7    Jenner, P.8
  • 94
  • 95
    • 0342614913 scopus 로고    scopus 로고
    • Relative sparing of calretinin containing neurons in the substantia nigra of 6-OHDA treated rat Parkinsonian model
    • Kim B.G., Shin D.H., Jeon G.S., Seo J.H., Kim Y.W., Jeon B.S., Cho S.S. Relative sparing of calretinin containing neurons in the substantia nigra of 6-OHDA treated rat Parkinsonian model. Brain Res 2000, 855:162-165.
    • (2000) Brain Res , vol.855 , pp. 162-165
    • Kim, B.G.1    Shin, D.H.2    Jeon, G.S.3    Seo, J.H.4    Kim, Y.W.5    Jeon, B.S.6    Cho, S.S.7
  • 96
    • 0034090891 scopus 로고    scopus 로고
    • AMPA receptor blockade improves levodopa-induced dyskinesia in MPTP monkeys
    • Konitsiotis S., Blanchet P.J., Verhagen L., Lamers E., Chase T.N. AMPA receptor blockade improves levodopa-induced dyskinesia in MPTP monkeys. Neurology 2000, 54:1589-1595.
    • (2000) Neurology , vol.54 , pp. 1589-1595
    • Konitsiotis, S.1    Blanchet, P.J.2    Verhagen, L.3    Lamers, E.4    Chase, T.N.5
  • 99
    • 33846908287 scopus 로고    scopus 로고
    • Endocan-nabinoid-mediated rescue of striatal LTD and motor deficits in Parkinson's disease models
    • Kreitzer A.C., Malenka R.C. Endocan-nabinoid-mediated rescue of striatal LTD and motor deficits in Parkinson's disease models. Nature 2007, 445:643-647.
    • (2007) Nature , vol.445 , pp. 643-647
    • Kreitzer, A.C.1    Malenka, R.C.2
  • 101
    • 0025771971 scopus 로고
    • The time course and magnitude of spontaneous recovery of parkinsonism produced by intracarotid administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine to monkeys
    • Kurlan R., Kim M.H., Gash D.M. The time course and magnitude of spontaneous recovery of parkinsonism produced by intracarotid administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine to monkeys. Ann Neurol 1991, 29:677-679.
    • (1991) Ann Neurol , vol.29 , pp. 677-679
    • Kurlan, R.1    Kim, M.H.2    Gash, D.M.3
  • 102
    • 0020680904 scopus 로고
    • Chronic parkinsonism in humans due to a product of meperidine-analog synthesis
    • Langston J.W., Ballard P., Tetrud J.W., Irwin I. Chronic parkinsonism in humans due to a product of meperidine-analog synthesis. Science 1983, 219:979-980.
    • (1983) Science , vol.219 , pp. 979-980
    • Langston, J.W.1    Ballard, P.2    Tetrud, J.W.3    Irwin, I.4
  • 103
    • 0021337873 scopus 로고
    • Selective nigral toxicity after systemic administration of 1-methyl-4-phenyl-1,2,5,6,-tetrahydropyridine (MPTP) in the squirrel monkey
    • Langston J.W., Forno S., Rebert C.S., Irwin I. Selective nigral toxicity after systemic administration of 1-methyl-4-phenyl-1,2,5,6,-tetrahydropyridine (MPTP) in the squirrel monkey. Brain Res 1984, 292:390-394.
    • (1984) Brain Res , vol.292 , pp. 390-394
    • Langston, J.W.1    Forno, S.2    Rebert, C.S.3    Irwin, I.4
  • 104
    • 3242686149 scopus 로고    scopus 로고
    • Corticostriatal plasticity: Life after the depression
    • Mahon S., Deniau J.M., Charpier S. Corticostriatal plasticity: Life after the depression. Trends Neurosci 2004, 27:460-467.
    • (2004) Trends Neurosci , vol.27 , pp. 460-467
    • Mahon, S.1    Deniau, J.M.2    Charpier, S.3
  • 106
    • 0021137683 scopus 로고
    • Intraneuronal generation of a pyridinium metabolite may cause drug-induced parkinsonism
    • Markey S.P., Johannessen J.N., Chiueh C.C., Burns R.S., Herkenham M.A. Intraneuronal generation of a pyridinium metabolite may cause drug-induced parkinsonism. Nature 1984, 311:464-467.
    • (1984) Nature , vol.311 , pp. 464-467
    • Markey, S.P.1    Johannessen, J.N.2    Chiueh, C.C.3    Burns, R.S.4    Herkenham, M.A.5
  • 107
    • 0032531781 scopus 로고    scopus 로고
    • Reduced striatal dopamine transporter density in abstinent methamphetamine and methcathinone users: Evidence from positron emission tomography studies with [11C]WIN-35,428
    • McCann U.D., Wong D.F., Yokoi F., Villemagne V., Dannals R.F., Ricaurte G.A. Reduced striatal dopamine transporter density in abstinent methamphetamine and methcathinone users: Evidence from positron emission tomography studies with [11C]WIN-35,428. J Neurosci 1998, 18:8417-8422.
    • (1998) J Neurosci , vol.18 , pp. 8417-8422
    • McCann, U.D.1    Wong, D.F.2    Yokoi, F.3    Villemagne, V.4    Dannals, R.F.5    Ricaurte, G.A.6
  • 108
    • 0030984414 scopus 로고    scopus 로고
    • Recovery of striatal dopamine function after acute amphetamine- and methamphetamine-induced neurotoxicity in the vervet monkey
    • Melega W.P., Raleigh M.J., Stout D.B., Lacan G., Huang S.-C., Phelps M.E. Recovery of striatal dopamine function after acute amphetamine- and methamphetamine-induced neurotoxicity in the vervet monkey. Brain Res 1997, 766:113-120.
    • (1997) Brain Res , vol.766 , pp. 113-120
    • Melega, W.P.1    Raleigh, M.J.2    Stout, D.B.3    Lacan, G.4    Huang, S.-C.5    Phelps, M.E.6
  • 109
    • 0037159608 scopus 로고    scopus 로고
    • Lysosomal malfunction accompanies alpha-synuclein aggregation in a progressive mouse model of Parkinson's disease
    • Meredith G.E., Totterdell S., Petroske E., Santa Cruz K., Callison R.C., Lau Y.S. Lysosomal malfunction accompanies alpha-synuclein aggregation in a progressive mouse model of Parkinson's disease. Brain Res 2002, 956:156-165.
    • (2002) Brain Res , vol.956 , pp. 156-165
    • Meredith, G.E.1    Totterdell, S.2    Petroske, E.3    Santa Cruz, K.4    Callison, R.C.5    Lau, Y.S.6
  • 110
    • 0022350722 scopus 로고
    • Sites of the neurotoxic action of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in the monkey include the ventral tegmental area and the locus coeruleus
    • Mitchell I.J., Cross A.J., Sambrook M.A., Crossman A.R. Sites of the neurotoxic action of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in the monkey include the ventral tegmental area and the locus coeruleus. Neurosci Lett 1985, 61:195-200.
    • (1985) Neurosci Lett , vol.61 , pp. 195-200
    • Mitchell, I.J.1    Cross, A.J.2    Sambrook, M.A.3    Crossman, A.R.4
  • 111
    • 0032581386 scopus 로고    scopus 로고
    • Spontaneous regeneration of nigrostriatal dopaminergic neurons in MPTP-treated C57BL/6 mice
    • Mitsumoto Y., Watanabe A., Mori A., Koga N. Spontaneous regeneration of nigrostriatal dopaminergic neurons in MPTP-treated C57BL/6 mice. Biochem Biophys Res Comm 1998, 248:660-663.
    • (1998) Biochem Biophys Res Comm , vol.248 , pp. 660-663
    • Mitsumoto, Y.1    Watanabe, A.2    Mori, A.3    Koga, N.4
  • 112
    • 0022922179 scopus 로고
    • Regional cerebral pharmacokinetics of the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine as examined by positron emission tomography in a baboon is altered by tranylcypromine
    • Moerlein S.M., Stocklin G., Pawlik G., Wienhard K., Heiss W.D. Regional cerebral pharmacokinetics of the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine as examined by positron emission tomography in a baboon is altered by tranylcypromine. Neurosci Lett 1986, 66:205-209.
    • (1986) Neurosci Lett , vol.66 , pp. 205-209
    • Moerlein, S.M.1    Stocklin, G.2    Pawlik, G.3    Wienhard, K.4    Heiss, W.D.5
  • 113
    • 0026587806 scopus 로고
    • Differential vulnerability of primate caudate-putament and striosime-matrix dopamie systems to the neurotoxic effects of 1-methyl-4-1,2,3,6-tetrahydropyridine
    • Moratalla R., Quinn B., DeLanney L.E., Irwin I., Langston J.W., Graybiel A.M. Differential vulnerability of primate caudate-putament and striosime-matrix dopamie systems to the neurotoxic effects of 1-methyl-4-1,2,3,6-tetrahydropyridine. Proc Natl Acad Sci USA 1992, 89:3859-3863.
    • (1992) Proc Natl Acad Sci USA , vol.89 , pp. 3859-3863
    • Moratalla, R.1    Quinn, B.2    DeLanney, L.E.3    Irwin, I.4    Langston, J.W.5    Graybiel, A.M.6
  • 114
    • 0025786135 scopus 로고
    • Changes in the nigrostriatal projections associated with recovery from lesion-induced behavioral asymmetry
    • Morgan S., Nomikos G., Huston J.P. Changes in the nigrostriatal projections associated with recovery from lesion-induced behavioral asymmetry. Behav Brain Res 1991, 46:157-165.
    • (1991) Behav Brain Res , vol.46 , pp. 157-165
    • Morgan, S.1    Nomikos, G.2    Huston, J.P.3
  • 115
    • 0023922934 scopus 로고
    • Immunohistochemical evaluation of the neurotoxic effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on dopaminergic nigrostriatal neurons of young adult mice using dopamine and tyrosine hydroxylase antibodies
    • Mori S., Fujitake J., Kuno S., Sano Y. Immunohistochemical evaluation of the neurotoxic effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on dopaminergic nigrostriatal neurons of young adult mice using dopamine and tyrosine hydroxylase antibodies. Neurosci Lett 1988, 90:57-62.
    • (1988) Neurosci Lett , vol.90 , pp. 57-62
    • Mori, S.1    Fujitake, J.2    Kuno, S.3    Sano, Y.4
  • 116
    • 0035353763 scopus 로고    scopus 로고
    • Plasticity of afferent fibers to striatal neurons bearing D1 dopamine receptors in Parkinson's disease
    • Muriel M.P., Agid Y., Hirsch E. Plasticity of afferent fibers to striatal neurons bearing D1 dopamine receptors in Parkinson's disease. Mov Disord 2001, 16:435-441.
    • (2001) Mov Disord , vol.16 , pp. 435-441
    • Muriel, M.P.1    Agid, Y.2    Hirsch, E.3
  • 117
    • 0023215260 scopus 로고
    • MPP+ (1-methyl-4-phenylpyridine) is a neurotoxin to dopamine-, norepinephrine- and serotonin-containing neurons
    • Namura I., Douillet P., Sun C.J., Pert A., Cohen R.M., Chiueh C.C. MPP+ (1-methyl-4-phenylpyridine) is a neurotoxin to dopamine-, norepinephrine- and serotonin-containing neurons. Eur J Pharmacol 1987, 136:31-37.
    • (1987) Eur J Pharmacol , vol.136 , pp. 31-37
    • Namura, I.1    Douillet, P.2    Sun, C.J.3    Pert, A.4    Cohen, R.M.5    Chiueh, C.C.6
  • 118
    • 3042833166 scopus 로고    scopus 로고
    • The NR2B-selective NMDA receptor antagonist CP-101,606 exacerbates L-DOPA-induced dyskinesia and provides mild potentiation of anti-parkinsonian effects of L-DOPA in the MPTP-lesioned marmoset model of Parkinson's disease
    • Nash J.E., Ravenscroft P., McGuire S., Crossman A.R., Menniti F.S., Brotchie J.M. The NR2B-selective NMDA receptor antagonist CP-101,606 exacerbates L-DOPA-induced dyskinesia and provides mild potentiation of anti-parkinsonian effects of L-DOPA in the MPTP-lesioned marmoset model of Parkinson's disease. Exp Neurol 2004, 188:471-479.
    • (2004) Exp Neurol , vol.188 , pp. 471-479
    • Nash, J.E.1    Ravenscroft, P.2    McGuire, S.3    Crossman, A.R.4    Menniti, F.S.5    Brotchie, J.M.6
  • 119
    • 0024393971 scopus 로고
    • Difference in recovery patterns of striatal dopamine content, tyrosine hydroxylase activity and total biopterin content after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) administration: A comparison of young and older mice
    • Nishi K., Kondo T., Narabayashi H. Difference in recovery patterns of striatal dopamine content, tyrosine hydroxylase activity and total biopterin content after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) administration: A comparison of young and older mice. Brain Res 1989, 489:157-162.
    • (1989) Brain Res , vol.489 , pp. 157-162
    • Nishi, K.1    Kondo, T.2    Narabayashi, H.3
  • 120
    • 33745499251 scopus 로고    scopus 로고
    • Histological effects of intraputaminal infusion of glial cell line-derived neurotrophic factor in Parkinson disease model macaque monkeys
    • discussion 275-266
    • Oiwa Y., Nakai K., Itakura T. Histological effects of intraputaminal infusion of glial cell line-derived neurotrophic factor in Parkinson disease model macaque monkeys. Neurol Med Chir (Tokyo) 2006, 46:267-275. discussion 275-266.
    • (2006) Neurol Med Chir (Tokyo) , vol.46 , pp. 267-275
    • Oiwa, Y.1    Nakai, K.2    Itakura, T.3
  • 121
    • 4043111360 scopus 로고    scopus 로고
    • Overlesioned hemiparkinsonian non human primate model: Correlation between clinical, neurochemical and histochemical changes
    • Oiwa Y., Eberling J.L., Nagy D., Pivirotto P., Emborg M.E., Bankiewicz K.S. Overlesioned hemiparkinsonian non human primate model: Correlation between clinical, neurochemical and histochemical changes. Front Biosci 2003, 8:155-166.
    • (2003) Front Biosci , vol.8 , pp. 155-166
    • Oiwa, Y.1    Eberling, J.L.2    Nagy, D.3    Pivirotto, P.4    Emborg, M.E.5    Bankiewicz, K.S.6
  • 122
    • 0029597780 scopus 로고
    • Increased susceptibility to MPTP toxicity in middle-aged rhesus monkeys
    • Ovadia A., Zhang Z., Gash D.M. Increased susceptibility to MPTP toxicity in middle-aged rhesus monkeys. Neurobiol Aging 1995, 16:931-937.
    • (1995) Neurobiol Aging , vol.16 , pp. 931-937
    • Ovadia, A.1    Zhang, Z.2    Gash, D.M.3
  • 123
    • 0029665122 scopus 로고    scopus 로고
    • Levodopa-induced dyskinesias improved by a glutamate antagonist in parkinsonian monkeys
    • Papa S.M., Chase T.N. Levodopa-induced dyskinesias improved by a glutamate antagonist in parkinsonian monkeys. Ann Neurol 1996, 39:574-578.
    • (1996) Ann Neurol , vol.39 , pp. 574-578
    • Papa, S.M.1    Chase, T.N.2
  • 124
    • 0033822025 scopus 로고    scopus 로고
    • Regional and postnatal heterogeneity of activity-dependent long-term changes in synaptic efficacy in the dorsal striatum
    • Partridge J.G., Tang K.C., Lovinger D.M. Regional and postnatal heterogeneity of activity-dependent long-term changes in synaptic efficacy in the dorsal striatum. J Neurophysiol 2000, 84:1422-1429.
    • (2000) J Neurophysiol , vol.84 , pp. 1422-1429
    • Partridge, J.G.1    Tang, K.C.2    Lovinger, D.M.3
  • 126
    • 0034935182 scopus 로고    scopus 로고
    • L-Dopa induces dyskinesia in normal monkeys: Behavioural and pharmacokinetic observations
    • Pearce R.K., Heikkila M., Linden I.B., Jenner P. L-Dopa induces dyskinesia in normal monkeys: Behavioural and pharmacokinetic observations. Psychopharmacology (Berl) 2001, 156:402-409.
    • (2001) Psychopharmacology (Berl) , vol.156 , pp. 402-409
    • Pearce, R.K.1    Heikkila, M.2    Linden, I.B.3    Jenner, P.4
  • 127
  • 128
    • 2942708228 scopus 로고    scopus 로고
    • Mechanism of neurodegenerative disease: Role of the ubiquitin proteasome system
    • Petrucelli L., Dawson T.M. Mechanism of neurodegenerative disease: Role of the ubiquitin proteasome system. Ann Med 2004, 36:315-320.
    • (2004) Ann Med , vol.36 , pp. 315-320
    • Petrucelli, L.1    Dawson, T.M.2
  • 129
    • 0001418286 scopus 로고    scopus 로고
    • The MPTP-lesioned non-human primate: A model for Parkinson' s disease
    • Prominent Press, Scottsdale, AZ, J. Marwah, H. Teitelbbaum (Eds.)
    • Petzinger G.M., Langston J.W. The MPTP-lesioned non-human primate: A model for Parkinson' s disease. Advances in Neurodegenerative Disease. Volume I: Parkinson's Disease 1998, 113-148. Prominent Press, Scottsdale, AZ. J. Marwah, H. Teitelbbaum (Eds.).
    • (1998) Advances in Neurodegenerative Disease. Volume I: Parkinson's Disease , pp. 113-148
    • Petzinger, G.M.1    Langston, J.W.2
  • 131
    • 31844445273 scopus 로고    scopus 로고
    • Behavioral Recovery in the MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine)-lesioned Squirrel Monkey (Saimiri sciureus): Analysis of Striatal Dopamine and the Expression of Tyrosine Hydroxylase and Dopamine Transporter Proteins
    • Petzinger G.M., Fisher B.E., Hogg E., Abernathy A., Arevalo P., Nixon K., Jakowec M.W. Behavioral Recovery in the MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine)-lesioned Squirrel Monkey (Saimiri sciureus): Analysis of Striatal Dopamine and the Expression of Tyrosine Hydroxylase and Dopamine Transporter Proteins. J Neuorsci Res 2006, 83:332-347.
    • (2006) J Neuorsci Res , vol.83 , pp. 332-347
    • Petzinger, G.M.1    Fisher, B.E.2    Hogg, E.3    Abernathy, A.4    Arevalo, P.5    Nixon, K.6    Jakowec, M.W.7
  • 133
    • 0035091767 scopus 로고    scopus 로고
    • The parkinsonian toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): A technical review of its utility and safety
    • Przedborski S., Jackson-Lewis V., Naini A.B., Jakowec M., Petzinger G., Miller R., Akram M. The parkinsonian toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): A technical review of its utility and safety. J Neurochem 2001, 76:1265-1274.
    • (2001) J Neurochem , vol.76 , pp. 1265-1274
    • Przedborski, S.1    Jackson-Lewis, V.2    Naini, A.B.3    Jakowec, M.4    Petzinger, G.5    Miller, R.6    Akram, M.7
  • 134
    • 0034668905 scopus 로고    scopus 로고
    • Firing patterns and correlations of spontaneous discharge of pallidal neurons in the normal and the tremulous 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine vervet model of parkinsonism
    • Raz A., Vaadia E., Bergman H. Firing patterns and correlations of spontaneous discharge of pallidal neurons in the normal and the tremulous 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine vervet model of parkinsonism. J Neurosci 2000, 20:8559-8571.
    • (2000) J Neurosci , vol.20 , pp. 8559-8571
    • Raz, A.1    Vaadia, E.2    Bergman, H.3
  • 135
    • 0029748597 scopus 로고    scopus 로고
    • Neuronal synchronization of tonically active neurons in the striatum of normal and parkinsonian primates
    • Raz A., Feingold A., Zelanskaya V., Vaadia E., Bergman H. Neuronal synchronization of tonically active neurons in the striatum of normal and parkinsonian primates. J Neurophysiol 1996, 76:2083-2088.
    • (1996) J Neurophysiol , vol.76 , pp. 2083-2088
    • Raz, A.1    Feingold, A.2    Zelanskaya, V.3    Vaadia, E.4    Bergman, H.5
  • 136
    • 0035256903 scopus 로고    scopus 로고
    • Activity of pallidal and striatal tonically active neurons is correlated in MPTP-treated monkeys but not in normal monkeys
    • Raz A., Frechter-Mazar V., Feingold A., Abeles M., Vaadia E., Bergman H. Activity of pallidal and striatal tonically active neurons is correlated in MPTP-treated monkeys but not in normal monkeys. J Neurosci 2001, 21:RC128.
    • (2001) J Neurosci , vol.21
    • Raz, A.1    Frechter-Mazar, V.2    Feingold, A.3    Abeles, M.4    Vaadia, E.5    Bergman, H.6
  • 137
    • 0036592025 scopus 로고    scopus 로고
    • Dopamine-dependent plasticity of corticostriatal synapses
    • Reynolds J.N., Wickens J.R. Dopamine-dependent plasticity of corticostriatal synapses. Neural Netw 2002, 15:507-521.
    • (2002) Neural Netw , vol.15 , pp. 507-521
    • Reynolds, J.N.1    Wickens, J.R.2
  • 138
    • 0023837672 scopus 로고
    • On the mechanisms underlying 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity. II. Susceptibility among mammalian species correlates with the toxin's metabolic patterns in brain microvessels and liver
    • Riachi N.J., Harik S.I., Kalaria R.N., Sayre L.M. On the mechanisms underlying 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity. II. Susceptibility among mammalian species correlates with the toxin's metabolic patterns in brain microvessels and liver. J Pharmacol Exp Ther 1988, 244:443-448.
    • (1988) J Pharmacol Exp Ther , vol.244 , pp. 443-448
    • Riachi, N.J.1    Harik, S.I.2    Kalaria, R.N.3    Sayre, L.M.4
  • 139
    • 0018824851 scopus 로고
    • Long-term effects of repeated methylamphetamine administration on dopamine and serotonin neurons in the rat brain: A regional study
    • Ricaurte G.A., Schuster C.R., Seiden L.S. Long-term effects of repeated methylamphetamine administration on dopamine and serotonin neurons in the rat brain: A regional study. Brain Res 1980, 193:153-163.
    • (1980) Brain Res , vol.193 , pp. 153-163
    • Ricaurte, G.A.1    Schuster, C.R.2    Seiden, L.S.3
  • 140
    • 0020084295 scopus 로고
    • Dopamine nerve terminal degeneration produced by high doses of methylamphetamine in the rat brain
    • Ricaurte G.A., Guillery R.W., Seiden L.S., Schuster C.R., Moore R.Y. Dopamine nerve terminal degeneration produced by high doses of methylamphetamine in the rat brain. Brain Res 1982, 235:93-103.
    • (1982) Brain Res , vol.235 , pp. 93-103
    • Ricaurte, G.A.1    Guillery, R.W.2    Seiden, L.S.3    Schuster, C.R.4    Moore, R.Y.5
  • 141
    • 0022477535 scopus 로고
    • Fate of nigrostriatal neurons in young mature mice given 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: A neurochemical and morphological reassessment
    • Ricaurte G.A., Langston J.W., DeLanney L.E., Irwin I., Peroutka S.J., Forno L.S. Fate of nigrostriatal neurons in young mature mice given 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: A neurochemical and morphological reassessment. Brain Res 1986, 376:117-124.
    • (1986) Brain Res , vol.376 , pp. 117-124
    • Ricaurte, G.A.1    Langston, J.W.2    DeLanney, L.E.3    Irwin, I.4    Peroutka, S.J.5    Forno, L.S.6
  • 142
    • 0023948634 scopus 로고
    • Normalization of extracellular dopamine in striatum following recovery from a partial unilateral 6-OHDA lesion of the substantia nigra: a microdialysis study in freely moving rats
    • Robinson T.E., Wishaw I.Q. Normalization of extracellular dopamine in striatum following recovery from a partial unilateral 6-OHDA lesion of the substantia nigra: a microdialysis study in freely moving rats. Brain Res 1988, 450:209-224.
    • (1988) Brain Res , vol.450 , pp. 209-224
    • Robinson, T.E.1    Wishaw, I.Q.2
  • 143
    • 0024328184 scopus 로고
    • Increased caudate dopamine turnover may contribute to the recovery of motor function in marmosets treated with the dopaminergic neurotoxin MPTP
    • Rose S., Nomoto M., Kelly E., Kilpatrick G., Jenner P., Marsden C.D. Increased caudate dopamine turnover may contribute to the recovery of motor function in marmosets treated with the dopaminergic neurotoxin MPTP. Neurosci Lett 1989, 101:305-310.
    • (1989) Neurosci Lett , vol.101 , pp. 305-310
    • Rose, S.1    Nomoto, M.2    Kelly, E.3    Kilpatrick, G.4    Jenner, P.5    Marsden, C.D.6
  • 144
    • 0027492176 scopus 로고
    • Age-related effects of 1-methyl-4-phenyl-,2,3,6-tetrahydropyridine treatment of common marmosets
    • Rose S., Nomoto M., Jackson E.A., Gibb W.R.G., Jaehnig P., Jenner P., Marsden C.D. Age-related effects of 1-methyl-4-phenyl-,2,3,6-tetrahydropyridine treatment of common marmosets. Eur J Pharm 1993, 230:177-185.
    • (1993) Eur J Pharm , vol.230 , pp. 177-185
    • Rose, S.1    Nomoto, M.2    Jackson, E.A.3    Gibb, W.R.G.4    Jaehnig, P.5    Jenner, P.6    Marsden, C.D.7
  • 145
    • 0035424801 scopus 로고    scopus 로고
    • Tyrosine hydroxylase and dopamine transporter expression in residual dopaminergic neurons: Potential contributors to spontaneous recovery from experimental parkinsonism
    • Rothblat D.S., Schroeder J.A., Schneider J.S. Tyrosine hydroxylase and dopamine transporter expression in residual dopaminergic neurons: Potential contributors to spontaneous recovery from experimental parkinsonism. J Neurosci Res 2001, 65:254-266.
    • (2001) J Neurosci Res , vol.65 , pp. 254-266
    • Rothblat, D.S.1    Schroeder, J.A.2    Schneider, J.S.3
  • 146
    • 0032502634 scopus 로고    scopus 로고
    • Sprouting of the serotonergic afferents into striatum after selective lesion of the dopaminergic system by MPTP in adult mice
    • Rozas G., Liste I., Guerra M.J., Labandeira-Garcia J.L. Sprouting of the serotonergic afferents into striatum after selective lesion of the dopaminergic system by MPTP in adult mice. Neurosci Lett 1998, 245:151-154.
    • (1998) Neurosci Lett , vol.245 , pp. 151-154
    • Rozas, G.1    Liste, I.2    Guerra, M.J.3    Labandeira-Garcia, J.L.4
  • 147
    • 0036751653 scopus 로고    scopus 로고
    • Negative allosteric modulation of AMPA-preferring receptors by the selective isomer GYKI 53784 (LY303070), a specific non-competitive AMPA antagonist
    • Ruel J., Guitton M.J., Puell J.L. Negative allosteric modulation of AMPA-preferring receptors by the selective isomer GYKI 53784 (LY303070), a specific non-competitive AMPA antagonist. CNS Drug Rev 2002, 8:235-254.
    • (2002) CNS Drug Rev , vol.8 , pp. 235-254
    • Ruel, J.1    Guitton, M.J.2    Puell, J.L.3
  • 148
    • 0026099265 scopus 로고
    • Neurochemical and behavioural features induced by chronic low dose treatment with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the common marmoset: Implications for Parkinson's disease?
    • Russ H., Mihatsch W., Gerlach M., Riederer P., Przuntek H. Neurochemical and behavioural features induced by chronic low dose treatment with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the common marmoset: Implications for Parkinson's disease?. Neurosci Lett 1991, 123:115-118.
    • (1991) Neurosci Lett , vol.123 , pp. 115-118
    • Russ, H.1    Mihatsch, W.2    Gerlach, M.3    Riederer, P.4    Przuntek, H.5
  • 149
    • 0142122419 scopus 로고    scopus 로고
    • Opioid antagonists increase the dyskinetic response to dopaminergic agents in parkinsonian monkeys: Interaction between dopamine and opioid systems
    • Samadi P., Gregoire L., Bedard P.J. Opioid antagonists increase the dyskinetic response to dopaminergic agents in parkinsonian monkeys: Interaction between dopamine and opioid systems. Neuropharmacology 2003, 45:954-963.
    • (2003) Neuropharmacology , vol.45 , pp. 954-963
    • Samadi, P.1    Gregoire, L.2    Bedard, P.J.3
  • 150
    • 2342576336 scopus 로고    scopus 로고
    • The opioid agonist morphine decreases the dyskinetic response to dopaminergic agents in parkinsonian monkeys
    • Samadi P., Gregoire L., Bedard P.J. The opioid agonist morphine decreases the dyskinetic response to dopaminergic agents in parkinsonian monkeys. Neurobiol Dis 2004, 16:246-253.
    • (2004) Neurobiol Dis , vol.16 , pp. 246-253
    • Samadi, P.1    Gregoire, L.2    Bedard, P.J.3
  • 153
    • 0025346258 scopus 로고
    • Chronic exposure to low doses of MPTP. I. Cognitive deficits in motor asymptomatic monkeys
    • Schneider J.S., Kovelowski C.J. Chronic exposure to low doses of MPTP. I. Cognitive deficits in motor asymptomatic monkeys. Brain Res 1990, 519:122-128.
    • (1990) Brain Res , vol.519 , pp. 122-128
    • Schneider, J.S.1    Kovelowski, C.J.2
  • 154
    • 0028825827 scopus 로고
    • Cognitive deficits precede motor deficits in a slowly progressing model of parkinsonism in the monkey
    • Schneider J.S., Pope-Coleman A. Cognitive deficits precede motor deficits in a slowly progressing model of parkinsonism in the monkey. Neurodegeneration 1995, 4:245-255.
    • (1995) Neurodegeneration , vol.4 , pp. 245-255
    • Schneider, J.S.1    Pope-Coleman, A.2
  • 155
    • 0028280215 scopus 로고
    • Volume transmission of dopamine over large distances may contribute to recovery from experimental parkinsonism
    • Schneider J.S., Rothblat D.S., DiStefano L. Volume transmission of dopamine over large distances may contribute to recovery from experimental parkinsonism. Brain Res 1994, 643:86-91.
    • (1994) Brain Res , vol.643 , pp. 86-91
    • Schneider, J.S.1    Rothblat, D.S.2    DiStefano, L.3
  • 156
    • 0028795054 scopus 로고
    • Differential recovery of volitional motor function, lateralized cognitive function, dopamine-agonist-induced rotation and dopaminergic parameters in monkeys made hemi-parkinsonian by intracarotid MPTP infusion
    • Schneider J.S., Lidsky T.I., Hawks T., Mazziotta J.C., Hoffman J.M. Differential recovery of volitional motor function, lateralized cognitive function, dopamine-agonist-induced rotation and dopaminergic parameters in monkeys made hemi-parkinsonian by intracarotid MPTP infusion. Brain Res 1995, 672:112-127.
    • (1995) Brain Res , vol.672 , pp. 112-127
    • Schneider, J.S.1    Lidsky, T.I.2    Hawks, T.3    Mazziotta, J.C.4    Hoffman, J.M.5
  • 157
    • 0141987877 scopus 로고    scopus 로고
    • Development of levodopa-induced dyskinesias in parkinsonian monkeys may depend upon rate of symptom onset and/or duration of symptoms
    • Schneider J.S., Gonczi H., Decamp E. Development of levodopa-induced dyskinesias in parkinsonian monkeys may depend upon rate of symptom onset and/or duration of symptoms. Brain Res 2003, 990:38-44.
    • (2003) Brain Res , vol.990 , pp. 38-44
    • Schneider, J.S.1    Gonczi, H.2    Decamp, E.3
  • 158
    • 0025728002 scopus 로고
    • Mechanism of accumulationof the 1-methyl-4-phenyl-phenylpyridinium species into mouse brain synaptosomes
    • Scotcher K.P., Irwin I., DeLanney L.E., Langston J.W., Di Monte D. Mechanism of accumulationof the 1-methyl-4-phenyl-phenylpyridinium species into mouse brain synaptosomes. J Neurochem 1991, 56:1602-1607.
    • (1991) J Neurochem , vol.56 , pp. 1602-1607
    • Scotcher, K.P.1    Irwin, I.2    DeLanney, L.E.3    Langston, J.W.4    Di Monte, D.5
  • 160
    • 0033031356 scopus 로고    scopus 로고
    • Frontal cognitive impairments and saccadic deficits in low-dose MPTP-treated monkeys
    • Slovin H., Abeles M., Vaadia E., Haalman I., Prut Y., Bergman H. Frontal cognitive impairments and saccadic deficits in low-dose MPTP-treated monkeys. J Neurophysiol 1999, 81:858-874.
    • (1999) J Neurophysiol , vol.81 , pp. 858-874
    • Slovin, H.1    Abeles, M.2    Vaadia, E.3    Haalman, I.4    Prut, Y.5    Bergman, H.6
  • 161
    • 0033031356 scopus 로고    scopus 로고
    • Frontal cognitive impairments and saccadic deficits in low-dose MPTP-treated monkeys
    • Slovin H., Abeles M., Vaadia E., Haalman I., Prut Y., Bergman H. Frontal cognitive impairments and saccadic deficits in low-dose MPTP-treated monkeys. J Neurophysiol 1999, 81:858-874.
    • (1999) J Neurophysiol , vol.81 , pp. 858-874
    • Slovin, H.1    Abeles, M.2    Vaadia, E.3    Haalman, I.4    Prut, Y.5    Bergman, H.6
  • 162
    • 0027492362 scopus 로고
    • Developing a stable bilateral model of parkinsonism in rhesus monkeys
    • Smith R., Zhang Z., Kurlan R., McDermott M., Gash D. Developing a stable bilateral model of parkinsonism in rhesus monkeys. Neuroscience 1993, 52:7-16.
    • (1993) Neuroscience , vol.52 , pp. 7-16
    • Smith, R.1    Zhang, Z.2    Kurlan, R.3    McDermott, M.4    Gash, D.5
  • 163
    • 0035801465 scopus 로고    scopus 로고
    • Regional differences in the expression of corticostriatal synaptic plasticity
    • Smith R., Musleh W., Akopian W., Buckwalter G., Walsh J.P. Regional differences in the expression of corticostriatal synaptic plasticity. Neuroscience 2001, 106:95-101.
    • (2001) Neuroscience , vol.106 , pp. 95-101
    • Smith, R.1    Musleh, W.2    Akopian, W.3    Buckwalter, G.4    Walsh, J.P.5
  • 164
    • 33746417219 scopus 로고    scopus 로고
    • Switching from levodopa to the long-acting dopamine D2/D3 agonist piribedil reduces the expression of dyskinesia while maintaining effective motor activity in MPTP-treated primates
    • Smith L.A., Jackson M.J., Johnston L., Kuoppamaki M., Rose S., Al-Barghouthy G., Del Signore S., Jenner P. Switching from levodopa to the long-acting dopamine D2/D3 agonist piribedil reduces the expression of dyskinesia while maintaining effective motor activity in MPTP-treated primates. Clin Neuropharmacol 2006, 29:112-125.
    • (2006) Clin Neuropharmacol , vol.29 , pp. 112-125
    • Smith, L.A.1    Jackson, M.J.2    Johnston, L.3    Kuoppamaki, M.4    Rose, S.5    Al-Barghouthy, G.6    Del Signore, S.7    Jenner, P.8
  • 165
  • 166
    • 0034108225 scopus 로고    scopus 로고
    • Inhibition of brain vesicular monoamine transporter (VMAT2) enhances 1-methyl-4-phenylpyridinium neurotoxicity in vivo in rat striata
    • Staal R., Sonsalla P. Inhibition of brain vesicular monoamine transporter (VMAT2) enhances 1-methyl-4-phenylpyridinium neurotoxicity in vivo in rat striata. J Pharmacol Exp Ther. 2000, 293(2):336-342.
    • (2000) J Pharmacol Exp Ther. , vol.293 , Issue.2 , pp. 336-342
    • Staal, R.1    Sonsalla, P.2
  • 167
    • 0036764831 scopus 로고    scopus 로고
    • The hyperkinetic abnormal movements scale: A tool for measuring levodopa-induced abnormal movements in squirrel monkeys
    • Tan L.C., Protell P.H., Langston J.W., Togasaki D.M. The hyperkinetic abnormal movements scale: A tool for measuring levodopa-induced abnormal movements in squirrel monkeys. Mov Disord 2002, 17:902-909.
    • (2002) Mov Disord , vol.17 , pp. 902-909
    • Tan, L.C.1    Protell, P.H.2    Langston, J.W.3    Togasaki, D.M.4
  • 169
    • 0025913348 scopus 로고
    • Grafting of fetal substantia nigra to striatum reverses behavioral deficits induced by MPTP in primates: A comparison with other types of grafts as controls
    • Taylor J.R., Elsworth J.D., Roth R.H., Sladek J.R., Collier T.J., Redmond D.E. Grafting of fetal substantia nigra to striatum reverses behavioral deficits induced by MPTP in primates: A comparison with other types of grafts as controls. Exp Brain Res 1991, 85:335-348.
    • (1991) Exp Brain Res , vol.85 , pp. 335-348
    • Taylor, J.R.1    Elsworth, J.D.2    Roth, R.H.3    Sladek, J.R.4    Collier, T.J.5    Redmond, D.E.6
  • 170
    • 0002269237 scopus 로고
    • Behavioral effects of MPTP administration in the vervet monkey. A primate model of Parkinson's disease
    • Plenum Press, New York, M.L. Woodruff, A.J. Nonneman (Eds.)
    • Taylor J.R., Elsworth J.D., Roth R.H., Sladek J.R., Redmond D.E. Behavioral effects of MPTP administration in the vervet monkey. A primate model of Parkinson's disease. Toxin-Induced Models of Neurological Disorders 1994, 139-174. Plenum Press, New York. M.L. Woodruff, A.J. Nonneman (Eds.).
    • (1994) Toxin-Induced Models of Neurological Disorders , pp. 139-174
    • Taylor, J.R.1    Elsworth, J.D.2    Roth, R.H.3    Sladek, J.R.4    Redmond, D.E.5
  • 171
    • 0031587263 scopus 로고    scopus 로고
    • Severe long-term 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in the vervet monkey (Cercopithecus aethiops sabaeus)
    • Taylor J.R., Elsworth J.D., Roth R.H., Sladek J.R., Redmond D.E. Severe long-term 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in the vervet monkey (Cercopithecus aethiops sabaeus). Neuroscience 1997, 81:745-755.
    • (1997) Neuroscience , vol.81 , pp. 745-755
    • Taylor, J.R.1    Elsworth, J.D.2    Roth, R.H.3    Sladek, J.R.4    Redmond, D.E.5
  • 172
    • 84996123497 scopus 로고
    • MPTP-induced parkinsonism as a model for Parkinson's disease
    • Tetrud J.W., Langston J.W. MPTP-induced parkinsonism as a model for Parkinson's disease. Acta Neurol Scand 1989, 126:35-40.
    • (1989) Acta Neurol Scand , vol.126 , pp. 35-40
    • Tetrud, J.W.1    Langston, J.W.2
  • 176
    • 0031975428 scopus 로고    scopus 로고
    • Blockade of glutamatergic transmission as treatment for dyskinesias and motor fluctuations in Parkinson's disease
    • Verhagen Metman L., Del Dotto P., Blanchet P.J., van den Munckhof P., Chase T.N. Blockade of glutamatergic transmission as treatment for dyskinesias and motor fluctuations in Parkinson's disease. Amino Acids 1998, 14:75-82.
    • (1998) Amino Acids , vol.14 , pp. 75-82
    • Verhagen Metman, L.1    Del Dotto, P.2    Blanchet, P.J.3    van den Munckhof, P.4    Chase, T.N.5
  • 177
    • 17344365599 scopus 로고    scopus 로고
    • Brain dopamine neurotoxicity in baboons treated with doses of methamphetamine comparable to those recreationally abused by humans: Evidence from [11C]WIN-35,428 positron emission tomography studies and direct in vitro determinations
    • Villemagne V., Yuan J., Wong D.F., Dannals R.F., Hatzidimitriou G., Mathews W.B., Ravert H.T., Musachio J., McCann U.D., Ricaurte G.A. Brain dopamine neurotoxicity in baboons treated with doses of methamphetamine comparable to those recreationally abused by humans: Evidence from [11C]WIN-35,428 positron emission tomography studies and direct in vitro determinations. J Neurosci 1998, 18:419-427.
    • (1998) J Neurosci , vol.18 , pp. 419-427
    • Villemagne, V.1    Yuan, J.2    Wong, D.F.3    Dannals, R.F.4    Hatzidimitriou, G.5    Mathews, W.B.6    Ravert, H.T.7    Musachio, J.8    McCann, U.D.9    Ricaurte, G.A.10
  • 178
    • 0034105157 scopus 로고    scopus 로고
    • Physiology of hypokinetic and hyperkinetic movement disorders: Model for dyskinesia
    • Vitek J.L., Giroux M. Physiology of hypokinetic and hyperkinetic movement disorders: Model for dyskinesia. Ann Neurol 2000, 47:S131-sS140.
    • (2000) Ann Neurol , vol.47
    • Vitek, J.L.1    Giroux, M.2
  • 179
    • 0035968065 scopus 로고    scopus 로고
    • Changes in striatal dopamine D3 receptor regulation during expression of and recovery from MPTP-induced parkinsonism
    • Wade T.V., Rothblat D.S., Schneider J.S. Changes in striatal dopamine D3 receptor regulation during expression of and recovery from MPTP-induced parkinsonism. Brain Res 2001, 905:111-119.
    • (2001) Brain Res , vol.905 , pp. 111-119
    • Wade, T.V.1    Rothblat, D.S.2    Schneider, J.S.3
  • 180
    • 33646139645 scopus 로고    scopus 로고
    • Dopaminergic control of corticostriatal long-term synaptic depression in medium spiny neurons is mediated by cholinergic interneurons
    • Wang Z., Kai L., Day M., Ronesi J., Yin H.H., Ding J., Tkatch T., Lovinger D.M., Surmeier D.J. Dopaminergic control of corticostriatal long-term synaptic depression in medium spiny neurons is mediated by cholinergic interneurons. Neuron 2006, 50:443-452.
    • (2006) Neuron , vol.50 , pp. 443-452
    • Wang, Z.1    Kai, L.2    Day, M.3    Ronesi, J.4    Yin, H.H.5    Ding, J.6    Tkatch, T.7    Lovinger, D.M.8    Surmeier, D.J.9
  • 181
    • 0023550354 scopus 로고
    • An immunohistochemical study of the acute and long-term effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in the marmoset
    • Waters C.M., Hunt S.P., Jenner P., Marsden C.D. An immunohistochemical study of the acute and long-term effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in the marmoset. Neuroscience 1987, 23:1025-1039.
    • (1987) Neuroscience , vol.23 , pp. 1025-1039
    • Waters, C.M.1    Hunt, S.P.2    Jenner, P.3    Marsden, C.D.4
  • 182
    • 0038389600 scopus 로고    scopus 로고
    • Pathophysiology of Parkinson's Disease: The MPTP primate model of the human disorder
    • Wichmann T., DeLong M.R. Pathophysiology of Parkinson's Disease: The MPTP primate model of the human disorder. Ann NY Acad Sci 2003, 991:199-216.
    • (2003) Ann NY Acad Sci , vol.991 , pp. 199-216
    • Wichmann, T.1    DeLong, M.R.2
  • 183
    • 0032462195 scopus 로고    scopus 로고
    • The effects of methamphetamine on the production of free radicals and oxidative stress
    • Yamamoto B.K., Zhu W. The effects of methamphetamine on the production of free radicals and oxidative stress. J Pharmacol Exp Ther 1998, 287:107-114.
    • (1998) J Pharmacol Exp Ther , vol.287 , pp. 107-114
    • Yamamoto, B.K.1    Zhu, W.2
  • 184
    • 0030687682 scopus 로고    scopus 로고
    • Do compensatory processes underlie the preclinical phase of neurodegenerative disease? Insights from an animal model of parkinsonism
    • Zigmond M.J. Do compensatory processes underlie the preclinical phase of neurodegenerative disease? Insights from an animal model of parkinsonism. Neurobiol Dis 1997, 4:247-253.
    • (1997) Neurobiol Dis , vol.4 , pp. 247-253
    • Zigmond, M.J.1
  • 185
    • 0025373167 scopus 로고
    • Compensations after lesions of central dopaminergic neurons: Some clinical and basic implications
    • Zigmond M.J., Abercrombie E.D., Berger T.W., Grace A.A., Sticker E.M. Compensations after lesions of central dopaminergic neurons: Some clinical and basic implications. Trends Neurosci 1990, 13:290-295.
    • (1990) Trends Neurosci , vol.13 , pp. 290-295
    • Zigmond, M.J.1    Abercrombie, E.D.2    Berger, T.W.3    Grace, A.A.4    Sticker, E.M.5
  • 186
    • 0028239552 scopus 로고
    • In brown Norway rats, MPP+ is accumulated in the nigrostriatal dopaminergic terminals but is not neurotoxic: A model of natural resistance to MPTP toxicity
    • Zuddas A., Fascetti F., Corsini G.U., Piccardi M.P. In brown Norway rats, MPP+ is accumulated in the nigrostriatal dopaminergic terminals but is not neurotoxic: A model of natural resistance to MPTP toxicity. Exp Neurol 1994, 127:54-61.
    • (1994) Exp Neurol , vol.127 , pp. 54-61
    • Zuddas, A.1    Fascetti, F.2    Corsini, G.U.3    Piccardi, M.P.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.